Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer

This study has been completed.
Sponsor:
Collaborators:
Tufts Medical Center
Information provided by:
Rogers Sciences Inc.
ClinicalTrials.gov Identifier:
NCT01262716
First received: December 15, 2010
Last updated: October 24, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)